Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Salam

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Expert Opinion on Investigational Drugs|August 29, 2003
Low molecular weight heparins combined with platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromesAmar M Salam
Expert Opinion on Investigational Drugs|July 2, 2003
Rate control versus rhythm control for the management of atrial fibrillation: the verdict of the AFFIRM trialAmar M Salam
Expert Opinion on Investigational Drugs|February 28, 2003
Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarctionAmar M Salam
Expert Opinion on Investigational Drugs|October 2, 2003
Is there a role for oral blockade of platelet glycoprotein IIb/IIIa receptors in coronary and cerebrovascular disease?Amar M Salam
Annals of Saudi Medicine|November 1, 1995
The single gallbladder stone: Is it innocent?I M Salam
Heart Views : the Official Journal of the Gulf Heart Association|December 6, 2019
The Invention of Electrocardiography MachineAmar M Salam
Expert Opinion on Investigational Drugs|June 2, 2005
The therapeutic potential of vasopressin receptor antagonists in congestive heart failureAmar M Salam
Journal of Nurse-Midwifery|November 1, 1993
Annual Student Report to the American College of Nurse-MidwivesC M Salam
Expert Opinion on Investigational Drugs|June 5, 2003
Evolving role of bivalirudin in percutaneous coronary interventions; impact of the REPLACE-2 studyAmar M Salam
Expert Opinion on Investigational Drugs|April 23, 2004
Angiotensin receptor blockers in acute myocardial infarctionAmar M Salam
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Expert Opinion on Investigational Drugs|August 29, 2003
Low molecular weight heparins combined with platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromesAmar M Salam
Expert Opinion on Investigational Drugs|July 2, 2003
Rate control versus rhythm control for the management of atrial fibrillation: the verdict of the AFFIRM trialAmar M Salam
Expert Opinion on Investigational Drugs|February 28, 2003
Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarctionAmar M Salam
Expert Opinion on Investigational Drugs|October 2, 2003
Is there a role for oral blockade of platelet glycoprotein IIb/IIIa receptors in coronary and cerebrovascular disease?Amar M Salam
Annals of Saudi Medicine|November 1, 1995
The single gallbladder stone: Is it innocent?I M Salam
Heart Views : the Official Journal of the Gulf Heart Association|December 6, 2019
The Invention of Electrocardiography MachineAmar M Salam
Expert Opinion on Investigational Drugs|June 2, 2005
The therapeutic potential of vasopressin receptor antagonists in congestive heart failureAmar M Salam
Journal of Nurse-Midwifery|November 1, 1993
Annual Student Report to the American College of Nurse-MidwivesC M Salam
Expert Opinion on Investigational Drugs|June 5, 2003
Evolving role of bivalirudin in percutaneous coronary interventions; impact of the REPLACE-2 studyAmar M Salam
Expert Opinion on Investigational Drugs|April 23, 2004
Angiotensin receptor blockers in acute myocardial infarctionAmar M Salam
Pageof 13